nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Current and Emerging Inhaled Therapies of Repositioned Drugs
|
Cipolla, David |
|
2018 |
133 |
C |
p. 1-4 |
artikel |
2 |
Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases
|
Newman, Stephen P. |
|
2018 |
133 |
C |
p. 5-18 |
artikel |
3 |
Editorial Board
|
|
|
2018 |
133 |
C |
p. ii |
artikel |
4 |
Inhalation of repurposed drugs to treat pulmonary hypertension
|
Gessler, Tobias |
|
2018 |
133 |
C |
p. 34-44 |
artikel |
5 |
Orally inhaled migraine therapy: Where are we now?
|
Stapleton, Kevin W. |
|
2018 |
133 |
C |
p. 131-134 |
artikel |
6 |
Phage therapy for respiratory infections
|
Chang, Rachel Yoon Kyung |
|
2018 |
133 |
C |
p. 76-86 |
artikel |
7 |
Regulatory pitfalls and opportunities when repurposing for inhalation therapy
|
Lyapustina, Svetlana |
|
2018 |
133 |
C |
p. 57-65 |
artikel |
8 |
Repurposing drugs as inhaled therapies in asthma
|
Anderson, Sandra D. |
|
2018 |
133 |
C |
p. 19-33 |
artikel |
9 |
Repurposing excipients as active inhalation agents: The mannitol story
|
Anderson, Sandra D. |
|
2018 |
133 |
C |
p. 45-56 |
artikel |
10 |
Repurposing of gamma interferon via inhalation delivery
|
Smaldone, Gerald C. |
|
2018 |
133 |
C |
p. 87-92 |
artikel |
11 |
Repurposing of statins via inhalation to treat lung inflammatory conditions
|
Bradbury, Peta |
|
2018 |
133 |
C |
p. 93-106 |
artikel |
12 |
Sphingolipids as targets for inhalation treatment of cystic fibrosis
|
Becker, Katrin Anne |
|
2018 |
133 |
C |
p. 66-75 |
artikel |
13 |
The potential to treat lung cancer via inhalation of repurposed drugs
|
Lee, Wing-Hin |
|
2018 |
133 |
C |
p. 107-130 |
artikel |